Rubén González del Río

A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Antimycobacterial Activity

J. Lelièvre, T. Dick, M. Gengenbacher, 2021, Antimicrobial Agents and Chemotherapy.

Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

John P. Overington, James R. Brown, Robert H Bates, 2015, PloS one.

Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

J. Lavandera, David Barros, Lluís Ballell, 2015, Antimicrobial Agents and Chemotherapy.

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening

C. Thompson, Alfonso Mendoza-Losana, S. Ramón-García, 2018, bioRxiv.

Repurposing clinically approved cephalosporins for tuberculosis therapy

C. Thompson, Fraser Cunningham, David Barros, 2016, Scientific Reports.

Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages

Y. Av‐Gay, F. Sorrentino, Rubén González del Río, 2015, Antimicrobial Agents and Chemotherapy.

Functional screening of selective mitochondrial inhibitors of Plasmodium

J. Lavandera, Alfonso Mendoza-Losana, J. Fuente, 2018, International journal for parasitology. Drugs and drug resistance.

Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline

G. Besra, J. Sacchettini, J. Lelièvre, 2020, FASEB bioAdvances.

Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection

J. Lelièvre, M. Zimmerman, T. Dick, 2023, Antimicrobial Agents and Chemotherapy.